Revised diagnostic criteria for neurocysticercosis

被引:213
|
作者
Del Brutto, O. H. [1 ]
Nash, T. E. [2 ]
White, A. C., Jr. [3 ]
Rajshekhar, V. [4 ]
Wilkins, P. P. [5 ]
Singh, G. [6 ]
Vasquez, C. M. [7 ]
Salgado, P. [8 ]
Gilman, R. H. [9 ]
Garcia, H. H. [10 ,11 ,12 ]
机构
[1] Univ Espiritu Santo Ecuador, Sch Med, Guayaquil, Ecuador
[2] NIAID, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[3] Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA
[4] Christian Med Coll & Hosp, Dept Neurol Sci, Vellore, Tamil Nadu, India
[5] Parasitol Serv, Marathon, FL USA
[6] Dayanand Med Coll, Dept Neurol, Ludhiana, Punjab, India
[7] Inst Natl Ciencias Neurol, Dept Neurosurg, Lima, Peru
[8] Natl Inst Neurol & Neurosurg Manuel Velasco Suare, Neuroimaging Unit, Mexico City, DF, Mexico
[9] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[10] Ctr Global Hlth, Tumbes, Peru
[11] Univ Peruana Cayetano Heredia, Sch Sci, Dept Microbiol, Lima, Peru
[12] Inst Natl Ciencias Neurol, Cysticercosis Unit, Jr Ancash 1271, Lima 1, Peru
基金
英国惠康基金;
关键词
Cysticercosis; Neurocysticercosis; Taenia solium; Diagnostic criteria; epilepsy; intracranial hypertension; BRUNS-SYNDROME; VENTRICULAR NEUROCYSTICERCOSIS; INTRACRANIAL CALCIFICATIONS; HUMAN CYSTICERCOSIS; COLLOID CYST; ASSAY; ALBENDAZOLE; MIMICKING; ENDOSCOPY; EPILEPSY;
D O I
10.1016/j.jns.2016.11.045
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: A unified set of criteria for neurocysticercosis (NCC) has helped to standardize its diagnosis in different settings. Methods: Cysticercosis experts were convened to update current diagnostic criteria for NCC according to two principles: neuroimaging studies are essential for diagnosis, and all other information provides indirect evidence favoring the diagnosis. Recent diagnostic advances were incorporated to this revised set. Results: This revised set is structured in absolute, neuroimaging and clinical/exposure criteria. Absolute criteria include: histological confirmation of parasites, evidence of subretinal cysts, and demonstration of the scolex within a cyst. Neuroimaging criteria are categorized as major (cystic lesions without scolex, enhancing lesions, multilobulated cysts, and calcifications), confirmative (resolution of cysts after cysticidal drug therapy, spontaneous resolution of single enhancing lesions, and migrating ventricular cysts on sequential neuroimaging studies) and minor (hydrocephalus and leptomeningeal enhancement). Clinical/exposure criteria include: detection of anticysticercal antibodies or cysticercal antigens by well-standardized tests, systemic cysticercosis, evidence of a household Taenia carrier, suggestive clinical manifestations, and residency in endemic areas. Besides patients having absolute criteria, definitive diagnosis can be made in those having two major neuroimaging criteria (or one major plus one confirmative criteria) plus exposure. For patients presenting with one major and one minor neuroimaging criteria plus exposure, definitive diagnosis of NCC requires the exclusion of confounding pathologies. Probable diagnosis is reserved for individuals presenting with one neuroimaging criteria plus strong evidence of exposure. Conclusions: This revised set of diagnostic criteria provides simpler definitions and may facilitate its more uniform and widespread applicability in different scenarios. (C) 2016 The Authors. Published by Elsevier B.V.
引用
收藏
页码:202 / 210
页数:9
相关论文
共 50 条
  • [31] Neurocysticercosis: A Review into Treatment Options, Indications, and Their Efficacy
    Hamamoto Filho, Pedro Tadao
    Rodriguez-Rivas, Roberto
    Fleury, Agnes
    RESEARCH AND REPORTS IN TROPICAL MEDICINE, 2022, 13 : 67 - 79
  • [32] Antibody Banding Patterns of the Enzyme-Linked Immunoelectrotransfer Blot and Brain Imaging Findings in Patients With Neurocysticercosis
    Arroyo, Gianfranco
    Rodriguez, Silvia
    Lescano, Andres G.
    Alroy, Karen A.
    Bustos, Javier A.
    Santivanez, Saul
    Gonzales, Isidro
    Saavedra, Herbert
    Javier Pretell, E.
    Gonzalez, Armando E.
    Gilman, Robert H.
    Tsang, Victor C. W.
    Garcia, Hector H.
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (02) : 282 - 288
  • [33] Epidemiology of cysticercosis and neurocysticercosis
    Bouteille, B.
    MEDECINE ET SANTE TROPICALES, 2014, 24 (04): : 367 - 374
  • [34] Current status and future perspectives on the medical treatment of neurocysticercosis
    Gonzales, Isidro
    Garcia, Hector H.
    PATHOGENS AND GLOBAL HEALTH, 2012, 106 (05) : 305 - 309
  • [35] New Insights Into Calcified Neurocysticercosis: Closing the Knowledge Gap
    Coyle, Christina M.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E2601 - E2603
  • [36] Clinical manifestations of neurocysticercosis
    San-juan Orta, D.
    NEUROLOGIA, 2009, 24 (05): : 331 - 335
  • [37] Treatment of neurocysticercosis: is it beneficial?
    Garg, Ravindra Kumar
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2008, 6 (04) : 435 - 440
  • [38] The radiologically isolated syndrome: revised diagnostic criteria
    Lebrun-Frenay, Christine
    Okuda, Darin T.
    Siva, Aksel
    Landes-Chateau, Cassandre
    Azevedo, Christina J.
    Mondot, Lydiane
    Carra-Dalliere, Clarisse
    Zephir, Helene
    Louapre, Celine
    Durand-Dubief, Francoise
    Le Page, Emmanuelle
    Bensa, Caroline
    Ruet, Aurelie
    Ciron, Jonathan
    Laplaud, David A.
    Casez, Olivier
    Mathey, Guillaume
    de Seze, Jerome
    Zeydan, Burcu
    Makhani, Naila
    Tutuncu, Melih
    Levraut, Michael
    Cohen, Mikael
    Thouvenot, Eric
    Pelletier, Daniel
    Kantarci, Orhun H.
    BRAIN, 2023, 146 (08) : 3431 - 3443
  • [39] Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution
    Garcia, Hector H.
    Del Brutto, Oscar H.
    EPILEPSY & BEHAVIOR, 2017, 76 : 158 - 162
  • [40] Neurocysticercosis: Diagnostic problems & current therapeutic strategies
    Rajshekhar, Vedantam
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2016, 144 : 319 - 326